Magnesium aspartate hydrochloride

Magnesium aspartate hydrochloride has been studied in 6 papers since 1985: 6 trials in people. The newest paper, Mar 1, 2011: “Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial”.

Intervention

6 papers study it17 findingsUpdated

PubChem

See all 6

“NIPTS was significantly more frequent and more severe in the placebo group than in the magnesium group, especially in bilateral damages.”
Oral magnesium intake reduces permanent hearing loss induced by noise exposureAmerican journal of otolaryngology1994doi:10.1016/0196-0709(94)90036-1

None of its findings points the other way.

  • 6 independent labs in 7 countries
  • Human trial6

Studies in people

See all 6

6 studies gave magnesium aspartate hydrochloride to people and measured what changed.

  • down: Decreases fasting plasma glucose

    up: Improves insulin sensitivity

    no change: Has no effect on blood pressure

    Randomized trial6 months

    In normomagnesemic, overweight, insulin resistant, non-diabetic subjects

    Diabetes, obesity & metabolism, Mar 1, 2011

  • down: Decreases diastolic blood pressure-3.4 mm Hg (95% CI 1.3, 5.6; P = 0.003)

    up: Increases urinary magnesium excretion+50%

    Randomized trial91 peopleWomenmiddle-aged and elderly6 mo

    Midlife adults; Older adults; Patient cohorts

    The American journal of clinical nutrition, Jul 1, 1994

  • down: Decreases noise-induced hearing loss

    Randomized trial300 peopleyoung2 months

    General population

    American journal of otolaryngology, Jan 1, 1994

  • no change: Has no effect on blood pressure

    no change: Has no effect on serum lipids

    Randomized trial13 people3 mo

    In magnesium-replete patients with mild hypertension

    The American journal of clinical nutrition, Apr 1, 1990

  • no change: Has no effect on blood pressure

    up: Increases urinary magnesium4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001

    up: Increases urinary calcium4.3 +/- 0.7 to 5.5 +/- 0.9 mmol/day P less than 0.01

    Randomized trial8 weeks

    Mild hypertensive subjects on a moderately low sodium diet

    Clinical and experimental pharmacology & physiology, Apr 1, 1989

What did studies of Magnesium aspartate hydrochloride find?

13

Studies of Magnesium aspartate hydrochloride measured 13 outcomes; the most studied are blood pressure (4 studies), urinary magnesium (2) and lipid profile (1).

Blood pressure

no changein humans4

4 studies
  1. Magnesium aspartate hydrochloride has no effect on blood pressure in humans.

    “Blood pressure and lipid profile did not show significant changes.”

    Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months

    Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

    Diabetes, obesity & metabolism

  2. Magnesium aspartate hydrochloride has no effect on blood pressure in humans.

    “magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”

    Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13

    Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

    The American journal of clinical nutrition

  3. Magnesium aspartate hydrochloride has no effect on blood pressure in humans.

    “There was no fall in blood pressure with magnesium supplementation and no significant difference in blood pressure between groups at the end of the study.”

    Human trialmild hypertensive subjects on a moderately low sodium diet8 weeks

    Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet

    Clinical and experimental pharmacology & physiology

  4. Magnesium aspartate hydrochloride has no effect on blood pressure in humans.

    “there was no fall in blood pressure compared with either treatment with placebo or values before treatment”

    Human trialessential hypertension15 mmol magnesium/dayone monthn = 17

    Lack of effect of oral magnesium on high blood pressure: a double blind study

    British medical journal (Clinical research ed.)

Urinary magnesium

upin humans2

2 studies
  1. Magnesium aspartate hydrochloride increases urinary magnesium in humans (4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001).

    “In the magnesium group there was an increase in urinary magnesium (4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001)”

    Human trialmild hypertensive subjects on a moderately low sodium dieturine10 mmol/day8 weeks

    Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet

    Clinical and experimental pharmacology & physiology

  2. Magnesium aspartate hydrochloride increases urinary magnesium in humans.

    “significant increase in urinary excretion of magnesium while taking magnesium aspartate”

    Human trialessential hypertension15 mmol magnesium/dayone monthn = 17

    Lack of effect of oral magnesium on high blood pressure: a double blind study

    British medical journal (Clinical research ed.)

More on Urinary magnesium

Lipid profile

no changein humans1

1 study
  1. Magnesium aspartate hydrochloride has no effect on lipid profile in humans.

    “Blood pressure and lipid profile did not show significant changes.”

    Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months

    Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

    Diabetes, obesity & metabolism

More on Lipid profile

Insulin sensitivity

upin humans1

1 study
  1. Magnesium aspartate hydrochloride improves insulin sensitivity in humans.

    “oral Mg supplementation improves insulin sensitivity even in normomagnesemic, overweight, non-diabetic subjects”

    Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months

    Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

    Diabetes, obesity & metabolism

Fasting plasma glucose

downin humans1

1 study
  1. Magnesium aspartate hydrochloride decreases fasting plasma glucose in humans.

    “Mg supplementation resulted in a significant improvement of fasting plasma glucose and some insulin sensitivity indices (ISIs) compared to placebo.”

    Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months

    Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

    Diabetes, obesity & metabolism

More on Fasting plasma glucose

Urinary magnesium excretion

upin humans1+50%

1 study
  1. Magnesium aspartate hydrochloride increases urinary magnesium excretion in humans (+50%).

    “Urinary magnesium excretion in the magnesium group increased by 50% during the intervention period.”

    Human trial20 mmol Mg/d6 mofemalesn = 91

    Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension

    The American journal of clinical nutrition

More on Urinary magnesium excretion

Diastolic blood pressure

downin humans1

1 study
  1. Magnesium aspartate hydrochloride decreases diastolic blood pressure in humans (-3.4 mm Hg (95% CI 1.3, 5.6; P = 0.003)).

    “diastolic blood pressure by 3.4 mm Hg (1.3, 5.6; P = 0.003) more in the magnesium group than in the placebo group”

    Human trial20 mmol Mg/d6 mofemalesn = 91

    Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension

    The American journal of clinical nutrition

Noise-induced hearing loss

downin humans1

1 study
  1. Magnesium aspartate hydrochloride decreases noise-induced hearing loss in humans.

    “NIPTS was significantly more frequent and more severe in the placebo group than in the magnesium group, especially in bilateral damages.”

    Human trial6.7 mmol (167 mg)2 months

    Oral magnesium intake reduces permanent hearing loss induced by noise exposure

    American journal of otolaryngology

More on Noise-induced hearing loss

cellular cation metabolism

no changein humans1

1 study
  1. Magnesium aspartate hydrochloride has no effect on cellular cation metabolism in humans.

    “magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”

    Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13

    Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

    The American journal of clinical nutrition

Serum lipids

no changein humans1

1 study
  1. Magnesium aspartate hydrochloride has no effect on serum lipids in humans.

    “magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”

    Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13

    Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension

    The American journal of clinical nutrition

More on Serum lipids

All 13

Latest